EBIT (Quarterly)

EBIT: Income before interest and taxes.

Pharming Group NV (PHGUF) had EBIT of $1.30M for the most recently reported fiscal quarter, ending 2026-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2026-06-30

Income Statement Financials
Revenue	$90.20M
Net Income	$1.60M
Cost of Goods Sold	$14.50M
Gross Profit	$75.70M
Operating Expenses	$88.90M
Operating Income	$1.30M
Non-Operating Income/Expense	$1.80M
Pre-Tax Income	$3.00M
Normalized Pre-Tax Income	$3.00M
Income after Taxes	$1.60M
Income from Continuous Operations	$1.60M
Consolidated Net Income/Loss	$1.60M
Normalized Income after Taxes	$1.60M
EBIT	$1.30M
EBITDA	$4.34M
Weighted-Average Shares Outstanding (Basic)	533.33M
Weighted-Average Shares Outstanding (Diluted)	533.33M
Earnings per Share (EPS) (Basic)	$0.00
Earnings per Share (EPS) (Diluted)	$0.00
Balance Sheet Financials
Current Assets	$280.69M
Property, Plant, and Equipment	$6.42M
Long-Term Assets	$187.29M
Total Assets	$467.98M
Current Liabilities	$93.25M
Long-Term Debt	$104.25M
Long-Term Liabilities	$104.25M
Total Liabilities	$197.49M
Common Equity	$270.49M
Tangible Shareholders Equity	$142.41M
Shareholders Equity	$270.49M
Common Shares Outstanding	707.78M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-7.71M
Cash Flow from Investing Activities	$-84.84M
Cash Flow from Financial Activities	$-11.67M
Beginning Cash	$145.31M
End Cash	$158.28M
Increase/Decrease in Cash	$12.98M
Stock-Based Compensation	$6.58M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.01
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.28
Debt to Equity Ratio	0.42
Gross Margin	83.92%
Operating Margin	1.44%
EBIT Margin	1.44%
EBITDA Margin	--
Pre-Tax Profit Margin	3.33%
Profit Margin	1.77%
Free Cash Flow	$-8.03M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.19
Inventory Turnover	0.22
Receiveable Turnover	1.58
Days Sales in Receivables	56.85
Return on Equity	0.59%
Return on Tangible Equity	1.12%
Return on Assets	0.34%
Return on Investments	0.43%
Book Value Per Share	$0.38
Free Cash Flow per Share	$-0.02
Operating Cash Flow per Share	$-0.01

Data from Zacks Investment Research, Inc.